KRTL BioTech

Record IPO rush of 2021 led to historically dismal returns for investors with no relief in sight

Record IPO rush of 2021 led to historically dismal returns for investors with no relief in sight

So far performance from 2021's public debuts has been lagging their historical average significantly, while rate hikes and share unlocks present further risks.